Antiplatelet Drugs [phsu]
Need [qlco]
Options [ftcn]
Direct [qlco]
Thromboxane [bacs, eico]
inhibitors [chvf]
Current [tmco]
Status [qlco]
antiplatelet therapy [topp]
Prevention [topp]
cardiovascular events [fndg]
Nature [idcn]
Efficacy [qlco]
Aspirin [orch, phsu]
Bleeding [patf]
Secondary Prevention [topp]
Relevant [qlco]
exception [idcn]
Patients [podg]
peripheral arterial disease [dsyn]
Trial [resa]
Primary Prevention [topp]
Aspirin [orch, phsu]
Limited [ftcn]
Challenge [clna]
Bleeding [patf]
Typical [qlco]
Example [cnce]
Primary Prevention [topp]
Diabetes Mellitus, Type 2 [dsyn]
Trial [resa]
Meta-Analysis [inpr]
confirmed [qlco]
limitations [ftcn]
Various [irda]
setting [ftcn]
clopidogrel [orch, phsu]
effective [qlco]
Aspirin [orch, phsu]
Negligible [qlco]
Bleeding [patf]
Combination [qlco]
Aspirin [orch, phsu]
clopidogrel [orch, phsu]
Provided [acty]
Satisfactory [inpr]
condition [dsyn]
High Risk [qlco]
long-term treatment [hlca]
Chronic disease [dsyn]
Stable [qlco]
CARDIOVASCULAR [bdsy]
Combination [qlco]
ASPIRIN/DIPYRIDAMOLE [orch, phsu]
Superior [spco]
Aspirin [orch, phsu]
Alone [qnco]
Equivalent [qlco]
clopidogrel [orch, phsu]
Alone [qnco]
Secondary Prevention [topp]
Cerebrovascular [qlco]
Patients [podg]
limitations [ftcn]
Efficacy [qlco]
Antiplatelet Agents [phsu]
Mechanism [ftcn]
Action [ftcn]
considered [idcn]
Treatment Failures [qlco]
Variability [cnce]
Response [orga]
Antiplatelet Drugs [phsu]
Play [dora]
Meaning [idcn]
Variability [cnce]
Response [orga]
Resistance [menp]
Drug Interactions [moft]
baseline [bodm]
Residual [qlco]
Platelet [cell]
Hyperactivity [fndg]
increased platelet [dsyn]
turnover [qnco]
pharmacogenetic [bmod]
Others [fndg]
Biological [bmod]
Response [orga]
Aspirin [orch, phsu]
clopidogrel [orch, phsu]
Clinical setting [spco]
Diabetes [dsyn]
Obesity [dsyn]
Syndromes, Acute Coronary [dsyn]
Correlation [qlco]
Biological [bmod]
Resistance [menp]
Impaired [ftcn]
Efficacy [qlco]
Aspirin [orch, phsu]
clopidogrel [orch, phsu]
Currently [tmco]
Accepted [qlco]
limitations [ftcn]
Methods [inpr]
Platelet [cell]
Response [orga]
concept [idcn]
tailoring [prog]
regimens [inpr]
Previous [tmco]
Laboratory [mnob, orgt]
point of care test [hlca]
Platelet Function [lbpr]
Trial [resa]
search [inpr]
Validation [resa]
New Agents [clas]
Known [qlco]
Mechanisms [ftcn]
Action [ftcn]
Increasing [ftcn]
Eager [menp]
Adenosine Diphosphate Receptor Antagonists [phsu]
prasugrel [orch, phsu]
Registered [hlca]
Ticagrelor [nnon, phsu]
cangrelor [nnon, phsu]
Mechanisms [ftcn]
Blockade [ftcn]
Thrombin induced platelet aggregation [clna]
vorapaxar [orch]
SCH [gngm]
Inhibition [menp]
Collagen [aapp, bacs, bodm]
Ristocetin [aapp, antb]
mediated [socb]
Platelet Function [lbpr]
DZ [geoa]
neglected [fndg]
Class [inpr]
Direct [qlco]
Thromboxane A>2< [eico]
antagonists [chvf]
Interest [menp]
Blocking [mobd]
effects [qlco]
Thromboxane [bacs, eico]
Platelets [cell]
Drugs [phsu]
Class [inpr]
terutroban [orch, phsu]
Sodium [bacs, elii]
picotamide [orch, phsu]
Cells [cell]
Thromboxane [bacs, eico]
sources [fndg]
Platelets [cell]
Enhance [acty]
Prostacyclin [bacs, eico, phsu]
production [ocac]
terutroban [orch, phsu]
presently [idcn]
tested [inpr]
peripheral arterial disease [dsyn]
Stroke prevention [topp]
picotamide [orch, phsu]
Market [geoa]
Italy [geoa]
cardiovascular events [fndg]
Mortality [qnco]
peripheral arterial disease [dsyn]
Patients [podg]
Diabetes [dsyn]
Available [ftcn]
Thromboxane [bacs, eico]
inhibitors [chvf]
Obtained [ftcn]
condition [dsyn]
Type 2 Diabetes [dsyn]
peripheral arterial disease [dsyn]
Known [qlco]
Refractory [ftcn]
Aspirin [orch, phsu]
